search
Back to results

Psychological Treatment of Depression in Women With Fibromyalgia (PCTFORDEPFM)

Primary Purpose

Fibromyalgia, Depressive Symptoms

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Cognitive Behavioral Therapy
Personal Construct Therapy
Sponsored by
University of Barcelona
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Fibromyalgia focused on measuring Depressive symptoms, Fibromyalgia, Cognitive Behavioral Therapy, Personal Constructs Therapy, Differential Efficacy

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of fibromyalgia in the health care system
  • A score above 7 on the Hospital Anxiety and Depression Scales

Exclusion Criteria:

  • Bipolar disorders
  • Psychotic symptoms
  • Substance abuse
  • Organic brain dysfunction
  • Mental retardation
  • Serious suicidal ideation
  • Receiving psychological treatment (unless it is suspended at the time of inclusion in the study)
  • Inability to communicate in Spanish
  • Substantial visual, hearing or cognitive deficits

Sites / Locations

  • Centro de Atención Primaria Les Hortes
  • Centro de Atención Primaria La Guineueta
  • Centro de Salud Mental de Nou Barris Nord
  • Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Cognitive Behavioral Therapy

Personal Construct Therapy

Arm Description

Cognitive Behavioral Therapy delivered in individual format.

Personal Constructs Therapy delivered in individual format.

Outcomes

Primary Outcome Measures

Change from Baseline in the Hospital Anxiety and Depression Scale at the end of therapy and 6-month follow-up.
To assess change in the severity of depressive symptoms with a self-report instrument.

Secondary Outcome Measures

Change from baseline in the Hamilton-Depression Rating Scale at the end of therapy and 6-month follow-up.
To assess change in the severity of depressive symptoms with a clinician-administered instrument.
Change from baseline in the Fibromyalgia Impact Questionnaire at the end of therapy and 6-month follow-up.
To assess change in the impact of fibromyalgia on functional capacity and quality of life.

Full Information

First Posted
March 14, 2016
Last Updated
March 21, 2020
Sponsor
University of Barcelona
Collaborators
Universidad Nacional de Educación a Distancia, University of Hertfordshire, University of Memphis, Arborétum
search

1. Study Identification

Unique Protocol Identification Number
NCT02711020
Brief Title
Psychological Treatment of Depression in Women With Fibromyalgia
Acronym
PCTFORDEPFM
Official Title
Psychological Treatment of Depression in Women With Fibromyalgia: Differential Efficacy and Factors Predictive of Outcome
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Completed
Study Start Date
March 1, 2016 (Actual)
Primary Completion Date
April 8, 2019 (Actual)
Study Completion Date
December 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Barcelona
Collaborators
Universidad Nacional de Educación a Distancia, University of Hertfordshire, University of Memphis, Arborétum

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to perform an efficacy study of Personal Construct Therapy, which focuses on the construction of self and others, for women diagnosed with fibromyalgia who have also comorbid depressive symptoms. To that aim, it will be compared with Cognitive Behavioral Therapy, which is an already well-established treatment in this area.
Detailed Description
Fibromyalgia is one of the most demanding health issues nowadays due to the high level of suffering and the deterioration of quality of life it entails. In addition, its high prevalence and the great expenses it implies for social and health care systems are also matter of both public and politic concern. Previous research has shown that the personal affliction triggered by fibromyalgia is influenced by psychological factors, which have also an effect on the socioeconomic burden of this disease as a consequence. Among these factors, depressive symptoms are highlighted in this study not only because they exacerbate the clinical profile of this type of patients, but also because they decrease their response to treatment, contributing to the chronicity of this disease. In fact, the treatment of depressive symptoms is already one of the therapeutic targets included in the most recommended multicomponent (and multidisciplinary) treatment guidelines for fibromyalgia. In spite of the growing number of studies supporting the efficacy of psychological therapies for fibromyalgia, many issues need further development. For example, current treatment recommendations for this syndrome suggest that the intervention must be tailored to the psychosocial and functioning profile of patients. However, research is still needed in order to enable the identification of key factors for clinical improvement. Similarly, it is crucial to identify and assess idiosyncratic psychological characteristics that may allow the psychological intervention to be effectively adapted. In addition, an evidence-based description of the mechanisms involved in change at different levels (including psychological and physical ones) has not been developed yet. The aim of this project is to perform an efficacy study of Personal Construct Therapy (PCT), which focuses on the construction of self and others, for women diagnosed with fibromyalgia who have also comorbid depressive symptoms. It will be compared with Cognitive Behavioral Therapy (CBT), which is a well-established treatment in this area. Both interventions will be performed in individual format. Depressive symptoms will be measured before and after treatments, along with other clinical and wellbeing-related variables. The cognitive indexes derived from the Repertory Grid Technique, such as cognitive conflicts, polarization and self-construction measures, will also be assessed. Moreover, the capacity of all these measures for predicting differential outcomes resulting from both treatments will also be estimated. The relevance of these cognitive indicators for depression and fibromyalgia has already been proven by this research group in previous studies. It is expected that PCT will be more effective than standard CBT in improving clinical symptoms and wellbeing. Additionally, the identification of patients' cognitive characteristics which may have a differential response to the components of each treatment will allow future adaptation of psychological interventions to the characteristics of patients, which will contribute in turn to the improvement of the existing treatments.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fibromyalgia, Depressive Symptoms
Keywords
Depressive symptoms, Fibromyalgia, Cognitive Behavioral Therapy, Personal Constructs Therapy, Differential Efficacy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
110 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Cognitive Behavioral Therapy
Arm Type
Active Comparator
Arm Description
Cognitive Behavioral Therapy delivered in individual format.
Arm Title
Personal Construct Therapy
Arm Type
Experimental
Arm Description
Personal Constructs Therapy delivered in individual format.
Intervention Type
Behavioral
Intervention Name(s)
Cognitive Behavioral Therapy
Other Intervention Name(s)
CBT
Intervention Description
Patients assigned to this arm will receive a maximum of 18 1-hour sessions of Cognitive Behavioral Therapy following the intervention techniques included in various group therapy manuals for patients with fibromyalgia, plus up to three 1-hour boost sessions between 3 and 5 months after the end of therapy. Techniques are adapted to individual format in the following modules: (1) Psychoeducation, (2) Relaxation, (3) Behavioral Activation, (4) Cognitive Restructuring, (5) Problem solving, (6) Assertiveness Training, and (7) Relapse Prevention.
Intervention Type
Behavioral
Intervention Name(s)
Personal Construct Therapy
Other Intervention Name(s)
PCT
Intervention Description
Patients will receive a maximum of 18 1-hour sessions of Personal Constructs Therapy plus up to three 1-hour boost sessions between 3 and 5 months after the end of therapy. The intervention will follow a protocol designed specifically for this project based on the clinical experience of a previous pilot study. It will consist of 4 stages: (1) Analysis of patient's request, goals setting, identification of the main dilemmas, and other personal meanings relevant for self and others' construction; (2) feedback on the assessment results and problem reframing in terms of a "dilemma" and/or other personal meanings; (3) work on the dilemmas and/or other aspects of the self and others' construction; and (4) end of the therapeutic process outlining personal projects and future perspectives.
Primary Outcome Measure Information:
Title
Change from Baseline in the Hospital Anxiety and Depression Scale at the end of therapy and 6-month follow-up.
Description
To assess change in the severity of depressive symptoms with a self-report instrument.
Time Frame
End of Therapy (18-30 weeks) and 6-month follow-up (42-54 weeks)
Secondary Outcome Measure Information:
Title
Change from baseline in the Hamilton-Depression Rating Scale at the end of therapy and 6-month follow-up.
Description
To assess change in the severity of depressive symptoms with a clinician-administered instrument.
Time Frame
End of Therapy (18-30 weeks) and 6-month follow-up (42-54 weeks)
Title
Change from baseline in the Fibromyalgia Impact Questionnaire at the end of therapy and 6-month follow-up.
Description
To assess change in the impact of fibromyalgia on functional capacity and quality of life.
Time Frame
End of Therapy (18-30 weeks) and 6-month follow-up (42-54 weeks)

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of fibromyalgia in the health care system A score above 7 on the Hospital Anxiety and Depression Scales Exclusion Criteria: Bipolar disorders Psychotic symptoms Substance abuse Organic brain dysfunction Mental retardation Serious suicidal ideation Receiving psychological treatment (unless it is suspended at the time of inclusion in the study) Inability to communicate in Spanish Substantial visual, hearing or cognitive deficits
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Guillem Feixas, Ph.D.
Organizational Affiliation
University of Barcelona
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centro de Atención Primaria Les Hortes
City
Barcelona
ZIP/Postal Code
08004
Country
Spain
Facility Name
Centro de Atención Primaria La Guineueta
City
Barcelona
ZIP/Postal Code
08042
Country
Spain
Facility Name
Centro de Salud Mental de Nou Barris Nord
City
Barcelona
ZIP/Postal Code
08042
Country
Spain
Facility Name
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
City
Madrid
ZIP/Postal Code
28040
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
32021219
Citation
Paz C, Aguilera M, Salla M, Compan V, Medina JC, Bados A, Garcia-Grau E, Castel A, Canete Crespillo J, Montesano A, Medeiros-Ferreira L, Feixas G. Personal Construct Therapy vs Cognitive Behavioral Therapy in the Treatment of Depression in Women with Fibromyalgia: Study Protocol for a Multicenter Randomized Controlled Trial. Neuropsychiatr Dis Treat. 2020 Jan 24;16:301-311. doi: 10.2147/NDT.S235161. eCollection 2020.
Results Reference
derived

Learn more about this trial

Psychological Treatment of Depression in Women With Fibromyalgia

We'll reach out to this number within 24 hrs